194sek
-8,3 %
Date:2025-05-13Time:18:00:00Latest report:Q1-2025List:First NorthTicker:NANEXA
Market Cap:304 msekEnterprise Value:277 msekNet Sales:19,5 msekEarnings:-31,1 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:1,94
MA50:1,34
MA200:1,57
Price/MA200:23,2 %
RSI (14):65,9
Price/MA50:44,4 %

Description

Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment